Home » Merrimack Raises $77M in Private Financing

Merrimack Raises $77M in Private Financing

Apr 15, 2011

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Merrimack Pharmaceuticals this week said that it has raised $77 million in a Series G private financing.

The firm, which is developing cancer therapeutics and companion molecular diagnostics, said that it would use the funds to support its pipeline of cancer therapeutics.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Scan

Embryos Edited in US

Technology Review reports that researchers in the US have used CRISPR to modify a number of human embryos.

True Blue

By introducing genes from butterfly peas and Canterbury bells, researchers in Japan have developed a blue chrysanthemum, according to NPR.

All the Plants

Plant researchers plan to sequence some 10,000 samples that represent the major plant clades, ScienceInsider reports.

This Week in Nature

In Nature this week: a Danish reference genome, and more.

Sponsorships

Privacy Policy.  Copyright © 2017 GenomeWeb LLC.  All Rights Reserved.